Skip to main content
Top
Published in:

Open Access 01-12-2024 | Epilepsy | Case report

Late-onset drug-resistant epilepsy in pyridoxamine 5′-phosphate oxidase deficiency: a case report

Authors: Erfan Naghavi, Afshan Davari, Amir Reza Bahadori, Mohammad Razmafrooz, Hamed AmiriFard, Iman Sabzgolin, Abbas Tafakhori, Mehrdad Sheikhvatan, Sara Ranji

Published in: Journal of Medical Case Reports | Issue 1/2024

Login to get access

Abstract

Background

Pyridoxamine 5′-phosphate oxidase deficiency is a rare inborn error of vitamin B6 metabolism that presents with drug-resistant epileptic seizures. However, the condition is responsive to supplementation with the active vitamin B6 metabolite pyridoxal 5′-phosphate and, in some cases, pyridoxine.

Case presentation

In this case report, a 10-year-old Iranian male of Fars ethnicity came to a regional hospital in Tehran, Iran with a chief complaint of tic-like movement. He had a history of unintentional, repetitive, and stereotypic movements of both arms since the age of 4 years. The physical examination depicted facial dimorphism. During admission, the patient experienced habitual hypermotor seizures and generalized tonic–clonic seizures. Ictal electroencephalography demonstrated a generalized background attenuation and bursts of generalized, predominantly left-sided, biphasic spike-wave complexes. Whole-genome sequencing revealed a pyridoxamine 5′-phosphate oxidase deficiency as the underlying cause of the drug-resistant seizures, resulting in a low serum level of pyridoxal 5′-phosphate. The patient underwent pyridoxine supplementation therapy, which ultimately resolved his seizures. At 6 months, he was seizure free.

Conclusion

Physicians ought to be aware of manifestations of vitamin B6 deficiency such as mimicking tic and consider it in the differential for drug-resistant epilepsy.
Literature
1.
go back to reference Bian X, Yang W, Lin J, Jiang B, Shao X. Hypothalamic–pituitary–adrenal axis and epilepsy. J Clin Neurol (Seoul, Korea). 2024;20(2):131–9.CrossRef Bian X, Yang W, Lin J, Jiang B, Shao X. Hypothalamic–pituitary–adrenal axis and epilepsy. J Clin Neurol (Seoul, Korea). 2024;20(2):131–9.CrossRef
3.
4.
5.
go back to reference García-Cazorla Á, Artuch R, Pearl PL. Disorders of neurotransmission neurotransmission disorders. In: Saudubray J-M, Baumgartner MR, García-Cazorla Á, Walter J, editors. Inborn metabolic diseases: diagnosis and treatment. Berlin: Springer; 2022. p. 547–70.CrossRef García-Cazorla Á, Artuch R, Pearl PL. Disorders of neurotransmission neurotransmission disorders. In: Saudubray J-M, Baumgartner MR, García-Cazorla Á, Walter J, editors. Inborn metabolic diseases: diagnosis and treatment. Berlin: Springer; 2022. p. 547–70.CrossRef
6.
go back to reference Mills PB, Camuzeaux SS, Footitt EJ, et al. Epilepsy due to PNPO mutations: genotype, environment and treatment affect presentation and outcome. Brain J Neurol. 2014;137(Pt 5):1350–60.CrossRef Mills PB, Camuzeaux SS, Footitt EJ, et al. Epilepsy due to PNPO mutations: genotype, environment and treatment affect presentation and outcome. Brain J Neurol. 2014;137(Pt 5):1350–60.CrossRef
8.
go back to reference Tong Y. Seizures caused by pyridoxine (vitamin B6) deficiency in adults: a case report and literature review. Intractable Rare Dis Res. 2014;3(2):52–6.CrossRefPubMedPubMedCentral Tong Y. Seizures caused by pyridoxine (vitamin B6) deficiency in adults: a case report and literature review. Intractable Rare Dis Res. 2014;3(2):52–6.CrossRefPubMedPubMedCentral
9.
go back to reference Alghamdi M, Bashiri FA, Abdelhakim M, et al. Phenotypic and molecular spectrum of pyridoxamine-5ʹ-phosphate oxidase deficiency: a scoping review of 87 cases of pyridoxamine-5ʹ-phosphate oxidase deficiency. Clin Genet. 2021;99(1):99–110.CrossRefPubMed Alghamdi M, Bashiri FA, Abdelhakim M, et al. Phenotypic and molecular spectrum of pyridoxamine-5ʹ-phosphate oxidase deficiency: a scoping review of 87 cases of pyridoxamine-5ʹ-phosphate oxidase deficiency. Clin Genet. 2021;99(1):99–110.CrossRefPubMed
10.
go back to reference Plecko B, Mills P. PNPO Deficiency. In: Adam MP, Feldman J, Mirzaa GM, et al., editors. GeneReviews(®). Seattle (WA): University of Washington, Seattle. Copyright© 1993–2024, University of Washington, Seattle. GeneReviews is a registered trademark of the University of Washington, Seattle. All rights reserved. 1993. Plecko B, Mills P. PNPO Deficiency. In: Adam MP, Feldman J, Mirzaa GM, et al., editors. GeneReviews(®). Seattle (WA): University of Washington, Seattle. Copyright© 1993–2024, University of Washington, Seattle. GeneReviews is a registered trademark of the University of Washington, Seattle. All rights reserved. 1993.
11.
go back to reference di Salvo ML, Mastrangelo M, Nogués I, et al. Pyridoxine-5’-phosphate oxidase (Pnpo) deficiency: clinical and biochemical alterations associated with the C.347g>A (P.Arg116gln) mutation. Mol Genet Metab. 2017;122(1–2):135–42.CrossRefPubMed di Salvo ML, Mastrangelo M, Nogués I, et al. Pyridoxine-5’-phosphate oxidase (Pnpo) deficiency: clinical and biochemical alterations associated with the C.347g>A (P.Arg116gln) mutation. Mol Genet Metab. 2017;122(1–2):135–42.CrossRefPubMed
12.
go back to reference Mills PB, Camuzeaux SSM, Footitt EJ, et al. Epilepsy due to PNPO mutations: genotype, environment and treatment affect presentation and outcome. Brain J Neurol. 2014;137(5):1350–60.CrossRef Mills PB, Camuzeaux SSM, Footitt EJ, et al. Epilepsy due to PNPO mutations: genotype, environment and treatment affect presentation and outcome. Brain J Neurol. 2014;137(5):1350–60.CrossRef
13.
go back to reference Mohanlal S, Bindu PS, Sureshbabu S, Kumar S. Variable treatment response in a patient with pyridoxal N phosphate oxidase (PNPO) deficiency—understanding the paradox. Epilepsy Behav Rep. 2020;14: 100357.CrossRefPubMedPubMedCentral Mohanlal S, Bindu PS, Sureshbabu S, Kumar S. Variable treatment response in a patient with pyridoxal N phosphate oxidase (PNPO) deficiency—understanding the paradox. Epilepsy Behav Rep. 2020;14: 100357.CrossRefPubMedPubMedCentral
14.
Metadata
Title
Late-onset drug-resistant epilepsy in pyridoxamine 5′-phosphate oxidase deficiency: a case report
Authors
Erfan Naghavi
Afshan Davari
Amir Reza Bahadori
Mohammad Razmafrooz
Hamed AmiriFard
Iman Sabzgolin
Abbas Tafakhori
Mehrdad Sheikhvatan
Sara Ranji
Publication date
01-12-2024
Publisher
BioMed Central
Keyword
Epilepsy
Published in
Journal of Medical Case Reports / Issue 1/2024
Electronic ISSN: 1752-1947
DOI
https://doi.org/10.1186/s13256-024-04876-7